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SUMMARY.-Groups of immature and mature mice were treated once with
DMBA by oral or intraperitoneal route, and the subsequent bilateral sequence
of ovarian changes leading to the development of unilateral granulosa cell
tumour was studied.
Early post-treatment changes included disappearance of oocytes and folli-
cles as well as increase of the stroma mass. The neoplastic development was
closely correlated to the rate of oocyte disappearance. The faster oocytes were
eliminated, the earlier tumours appeared. The early post-treatment changes
led to a stage of potential preneoplasia, characterized by diffuse luteinization
of the ovarian parenchyma. In some preneoplastic ovaries the luteinized
tissue underwent neoplastic transformation anddevelopedintoinvasiveluteoma.
In other preneoplastic ovaries foci of granulosa-like tumour cells appeared in
the luteinized tissue, representing the stage of microscopic granulosa cell
tumour. However, such microtumours could also develop within pre-existing
luteomata. Autoradiography after injection of thymidine-3H suggested that
the granulosa-like tumour cells developed as the result of undifferentiated
proliferation of luteinized cells.
So far the pathological ovarian evolution occurred bilaterally as well as
unilaterally. However, when a microscopic granulosa cell tumour by further
growth became a macroscopic granulosa cell tumour the contralateral ovary
invariably atrophied. This ultimate unilateral development coincided with a
continuous production of oestrogen by the granulosa cell tumour. The reason
for the contralateral atrophy is discussed in relation to the influence of the
hormonal balance on ovarian tumorigenesis.
THE carcinogenic hydrocarbon 9,10-dimethyl-1,2-benzanthracene (DMBA)
administered to sensitive strains of mice affects the ovaries and induces granulosa
cell tumours regardless of whether it is applied externally to the skin (Howell
et al., 1954; Marchant, 1957; Mody, 1960), orally (Biancifiori et al., 1961; Jull
et al., 1966; Krarup, 1967; Kuwahara, 1967), intraperitoneally (Krarup, 1967;
Kuwahara, 1967), intravenously (Kuwahara, 1967), subcutaneously (Shisa and
Nishizuka, 1968), or directly to the surface of the ovary (Krarup, 1969a).
Disappearance of oocytes precedes the development of ovarian tumours
induced by X-irradiation (Guthrie, 1958), intrasplenic ovary transplantation
(Guthrie, 1957), and DMBA treatment (Marchant, 1957; Krarup, 1967). A
common mechanism in the experimental induction of ovarian tumours in mice
would therefore seem to be the elimination of ova (Jull et al., 1966, Marchant,
1967; Krarup, 1969a).
Marchant (1961b) applied the two-stage model of initiation and promotion
in experimental carcinogenesis (Berenblum and Shubik, 1947) to the chemicalDMBA OVARIAN TUMORIGENESIS IN MICE
induction of ovarian tumours in mice and suggested DMBA to be the initiation
factor and the pituitary influence the promoting factor. This was based on the
observation, that preneoplastic changes (including depletion of oocytes and
follicles) readily developed after DMBA application in hypophysectomized
animals, while the further tumour development only occurred in the presence of
the pituitary (Marchant, 196la).
The initiation phase has recently been described in detail (Krarup, 1969b).
DMBA immediately affects the small oocytes and destroys a large proportion of
them. Secondarily the developing follicles are reduced in number and the ovaries
are prematurely depleted of oocytes.
The promotion phase is known to depend on the pituitary function (Marchant,
1961a); however, the presence of a normal ovary with its hormone production
inhibited tumorigenesis in unilateral preneoplastic ovaries grafted from donors
pretreated with DMBA (Marchant, 1960). The promotion phase therefore seems
to include a hormone dependent stage. As oocyte destruction occurs synchro-
nously and to the same extent in the two ovaries ofa mouse after DMBA treatment
(Krarup, 1969b), it would be expected that also tumour promotion occurred equally
in the two ovaries. However, the ultimate ovarian tumours are unilateral
(Howell et al., 1954; Mody, 1960; Krarup, 1967; Kuwahara, 1967; Shisa and
Nishizuka, 1968).
In the present study the gradual development of pathological changes in both
ovaries after DMBA treatment is described, and the correlation to the rate of
oocyte disappearance (Krarup, 1969a) is further explored. The histogenic
pathways of tumour development are studied, and a stage is described in the
neoplastic process, after which only one ovary continues its development while
the other one is arrested and atrophies. This stage coincides with changes in
the hormonal balance.
MATERIALS AND METHODS
Four hundred and ninety-one female virgin mice of the Bagg strain were used
for the investigation (Table I). The experimental procedure and information
on the strain and care of animals, as well as on the histological technique, has
previously been reported together with total and differential oocyte counts
(Krarup, 1969b).
Control groups. Two different groups of mice served as controls.
(1) 63 untreated virgin mice
(2) 30 immature mice were treated orally with 0 05 ml. olive oil and 39 intra-
peritoneally with 0-25 ml. olive oil.
The control mice were killed and examined at different ages (Table I, a-c).
DMBA orally. DMBA dissolved in olive oil was fed through a thin gastric
tube to anaesthetized mice. One hundred and eleven animals were treated at the
age of 21 days, i.e. in immaturity. Ninety-nine ofthese received 0-25 mg. DMBA
and 12 received 0 5 mg. DMBA. Sixty-one mice were treated at the age of
4 months, i.e. in maturity, with 1 mg. DMBA.
In order to describe the proliferation pattern of ovarian tissue after exposure
to the carcinogen 10 mice aged 6-9 months were injected intraperitoneally with
100 ,uCi tritiated thymidine (3HTdR). The mice were killed 1 hour later and
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autoradiographs of the serially sectioned ovaries were prepared (Pedersen and
Krarup, 1969) alternating with simple histological sections.
DMBA intraperitoneally. One hundred and twenty-two immature mice aged
21 days were injected intraperitoneally with 025 mg. DMBA dissolved in olive
oil. Sixty-five mature mice aged 4 months were treated intraperitoneally with
1 mg. DMBA in olive oil.
The DMBA treated mice were killed or died spontaneously at different ages
(Table I, d-g). Ovaries and organs macroscopically abnormal were removed for
examination.
Vaginal smears. In order to obtain information on the hormonal status of
the animals daily vaginal smears were taken from 55 control mice and 151 experi-
mental mice for 3 weeks before scheduled sacrifice.
RESULTS
Ovaries
Control mtice
The ovaries of all control mice were macroscopically normal with recognizable
follicles and corpora lutea. Spontaneous ovarian tumours did not occur.
The microscopic appearance of the normal Street mouse ovary at different
ages has previously been reported (Krarup, 1969a). The ovarian morphology in
Bagg mice is similar and is therefore only summarized here. Pathological changes
were not found at any age.
At all ages oocytes in different stages of follicle development characterized the
organs. Degeneration offollicles was likewise observed at all ages, most markedly
in the juvenile period. The stroma appeared in increasing amounts after the
fifth week of life and seemed to be derived from degenerated follicular material;
it could be slightly luteinized in areas. After the age of 42 days corpora lutea
were a characteristic structure in all ovaries. With increasing age pigmented cells
(Fekete, 1946; Deane and Fawsett, 1952; Thung et al., 1956) appeared in areas of
luteinized stroma as well as in corpora lutea, and in old animals pigmented tissue
became a prominent structure. Empty rings and pseudofollicles (" anovular
follicles ") (Thung et al., 1956; Krarup, 1967) as well as " Sertoli bodies " (Engle,
1946; Thung et al., 1956) were occasionally found in the ovaries of old animals.
They were spherical and composed of cells with bright nuclei containing a dark-
staining nucleolus and abundant cytoplasm with a reticular structure (Fig. 15).
The typical senile ovary had few oocytes, follicles, and corpora lutea. The
main component was non-luteinized stroma with many pigmented cells.
DMBA treated mice
A total of 359 mice was treated with DMBA; 98 ofthese were found dead before
scheduled killing (see Table I). Because of sometimes advanced autolysis,
microscopic examination of ovaries and other organs was impossible.
Two hundred and sixty-one DMBA treated animals were killed at different
ages according to a predetermined schedule.
A macroscopic ovarian tumour was found in a number of animals. With one
exception they were all unilateral, the contralateral ovary usually being consider-
ably smaller than normal (" pinhead ovary "). The largest diameter of the
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tumours varied from 3-5 mm. to 30 mm. with 10-20 mm. as the most common
size. Large subeapsular haemorrhages and necrotic areas containing cell detritus
were present in the large tumours. They were usually well encapsuled, though
adhesions to and displacement of neighbouring organs were common, sometimes
causing hydronephrosis and renal infection. All the ovaries in animals without
a macroscopic tumour were of normal size or only slightly smaller than normal.
Microscopic examination. Histological evaluation made it possible to divide
the ovaries into two groups: (1) Those which had not developed tumours (non-
tumour group) but showed (a) early post-treatment changes, (b) potential pre-
neoplastic changes (Krarup, 1969a), (c) premature senility or (d) atrophy, and
(2) those which had developed tumours (tumour group). According to the
different stages of neoplastic development, these were described as (a) luteoma,
(b) microscopic granulosa cell tumour (Mic. G.) or macroscopic granulosa cell
tumour (Mac. G.). This classification, however, is arbitrary, and transitional
stages were seen. Histologically normal ovaries were never found among the
DMBA treated animals.
In the following the main characteristics ofeach type ofpathology is described.
Their occurrences at different ages appear from Fig. 21 and 22, which summarize
the bilateral ovarian histology of all experimental mice advanced further than
early post treatment changes.
1. Non-turnmour group
(a) Early post-treatment changes.--A reduction in the oocyte number occurred
immediately after DMBA application, most markedly in the intraperitoneally
treated animals (Krarup, 1969b). In the first week after feeding DMBA to
21-days-old mice, degenerated small oocytes and empty spaces left by them
were noted in the ovarian cortex. The number ofdeveloping follicles was reduced
2 weeks after treatment, and follicle degeneration and the amount of stroma
increased concurrently. Some empty rings and pseudofollicles, and a rim of
small dark-staining cells appeared in the periphery in the third week. Though the
oocyte population at the beginning of the fourth post-treatment week (age 42
days) was reduced to 10 % of a normal complement, follicles came to ovulation,
eggs were seen in the tube and corpora lutea were formed.
Similar changes were seen after feeding DMBA to 4-month-old animals.
In addition a luteinization of the stroma and an accumulation of corpora lutea
occurred. In spite of the severe reduction of the number of germ cells, ovulation
continued.
After intraperitoneal injection ofDMBA to immature mice the capillaries were
dilated and an extensive degeneration of developing follicles occurred already in
the first week. Empty rings appeared earlier than after treatment by mouth.
The ovaries looked " underdeveloped " because of the severe degenerative
changes, the low number of healthy follicles and the lack of corpora lutea, which
were still not found 4 weeks after treatment. Degenerative changes could
proceed to leave only traces of atrophied follicular material or patches of con-
nective tissue at the site ofthe ovaries (total degeneration).
Such severe ovarian degeneration also happened after intraperitoneal injection
to 4-month-old mice; however, most of them showed luteinization of stroma as
well as persistence and merging of corpora lutea, thus tending towards potential
preneoplasia.
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(b) Potential preneoplasia was the result of further progression of the early
post-treatment changes. In orally treated animals potential preneoplasia
(preneoplastic ovaries) was characterized by a diffuse luteinization of the stroma
and an accumulation of corpora lutea (Fig. 1) which merged and formed a central
mass of diffusely luteinized material together with the luteinized stroma (Fig. 2).
This centre was covered by a more or less complete rim ofempty rings and pseudo-
follicles (Fig. 2 and 3). Recently ruptured follicles and ova in the tube were
seen at times, even when the preneoplastic changes were advanced and only a few
oocytes were left in the ovaries (Fig. 4). The degree ofpreneoplastic development
was correlated to the number of oocytes present in the ovaries. At comparable
ages, the less advanced preneoplasia was found in those ovaries that contained the
highest number of oocytes. Survival of oocytes thus seemed to delay the process.
The prenoeplastic ovaries appeared somewhat differently in the intraperi-
toneally treated animals. The ovaries were considerably smaller than after
feeding of DMBA, and empty rings or pseudofollicles were few or absent.
Dilatation of vessels was common and luteinized tissue was the main structure
found. In only a few ofthese ovaries could remnants ofcorpora lutea beidentified.
In preneoplastic ovaries aswell as in other types ofpathological ovaries " Sertoli
bodies " were at times seen (Fig. 15).
(c) Prem,ature senile changes were occasionally found. Such ovaries were like
the senile ovaries in old control mice, but they occurred at younger ages. Non-
luteinized stroma and pigmented tissue were the main components.
(d) Atrophy. The atrophic ovaries were very small (pinhead ovaries). A broad
rim of empty rings, pseudofollicles and small dark-staining cells covered a centre
of stroma cells and pigmented cells (Fig. 5). Luteinized tissue was not found in
the atrophic ovaries.
2. Tumour group
(a) Luteoma.- The ovaries of this group were of normal or slightly reduced
size. On microscopical examination all of the structures described for potential
preneoplastic ovaries could be found, however, the reason for classifying them as
luteoma was that the luteinized tissue showed neoplastic properties: penetration
through the ovarian capsule, invasion into the periovarian fat (Fig. 6 and Fig. 11),
and areas of mitotic activity within the luteinized tissue. The cells ofthe luteoma
showed nuclear anisocytosis and the abundant cytoplasma contained eosinophilic
granula. The luteomas contained very few (6-9-month-old animals) or no
oocytes (9-12-month-old animals).
In one case a papilliferous cystadenoma was present within an invasive
luteoma (Fig. 6).
(b) Microscopic granulosa cell tumour (Mic. G.).- Mic. G. were characterized by
proliferation of granulosa-like tissue within an ovary that was macroscopically
not enlarged. Such development was seen either in potential preneoplastic
ovaries (early occurrence of Mic. G.) or in luteomas (late occurrence of Mic. G.).
The tumour cells were microscopically similar to granulosa cells of normal
follicles. They were found in small or large foci without any specific pattern, and
numerous mitosis suggested a rapid growth. Small cysts were at times present.
In typical cases of Mic. G. developing within a preneoplastic ovary, large tumour
foci reduced the remaining luteinized tissue to a semilunar shell at one ofthe poles
of the ovary (Fig. 7 and 8), or a preneoplastic ovary-rest could be found as an
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appendix to the tumour (Fig. 9). Sometimes areas oftheca cell proliferation were
found side by side with the granulosa-like tumour cells. One or two oocytes were
occasionally found in the preneoplastic ovary-rest (Fig. 9), but usually oocytes
or follicles were absent in ovaries showing Mic. G. As in preneoplastic ovaries the
abnormal ovarian growth seemed to be correlated to the rate of disappearance of
oocytes: at the age of 3 months, 2 mice had a Mic. G.; these ovaries contained
considerably fewer oocytes than others, that still showed preneoplastic changes.
When Mic. G. developed within a luteoma (Fig. 10) the proliferation of
granulosa-like cells could be found in areas ofinvasion (Fig. 11) or diffusely among
the luteoma cells (Fig. 12). In other ovaries foci had grown to a bulk ofgranulosa-
like tumour tissue replacing most of the previously luteinized organ (Fig. 13).
EXPLANATION OF PLATES
FIG. 1.-Preneoplastic ovary showing accumulation and merging ofcorpora lutea. The section
contains a residual follicle. x 34.
FIG. 2.-Preneoplastic ovary. The centre of diffusely luteinized cell material is covered by a
rim of empty rings and pseudofollicles. x 34.
FIG. 3. Preneoplastic ovary with a peripheral rim of empty rings and pseudofollicles and a
centre of luteinized tissue. The frame refers to Fig. 18. x 85.
FIG. 4.-Preneoplastic luteinized ovary showing signs of ovulation with two eggs in the tube
and two recently ruptured follicles. Only eight oocytes were left in this ovary. x 20.
FIG. 5.-Atrophic ovary composed of a broad rim of empty rings and pseudofollicles and a
centre of stroma and pigmented cells. x 37.
FIG. 6.-Luteoma. The luteoma cells invade the periovarian fat capsule. A papilliferous
cystadenoma has developed within the luteoma. x 92.
FIG. 7.-Early microscopic granulosa cell tumour arising in a preneoplastic ovary. Small cysts
are present within foci ofgranulosa-like tumour cells. Preneoplastic tissue is present at the
upper pole of the ovary. x 37.
FIG. 8. Microscopic granulosa cell tumour (detail of Fig. 7). The granulosa-like tissue, show-
ing mitosis, has reduced preneoplastic luteinized tissue to a semilunar shell. x 230.
FIG. 9. Early microscopic granulosa cell tumour arising in a preneoplastic ovary. The
upper (larger) mass consists ofgranulosa-like tissue without any specific growth pattern apart
from the presence of a cyst; the lower mass shows a more whirled structure and is composed
mainly of theca-like cells. A preneoplastic ovary rest containing two follicles is found as
an appendix to the tumour. x 23.
FIG. 10.-Late microscopic granulosa cell tumour developing within a luteoma. Luteoma
cells invade the periovarian fat at the hilus. In this area as well as in central islands of
luteoma tissue granulosa-like cells arise diffusely. x 23.
FIG. 11. Granulosa-like cells (darkstaining) arising among luteoma cells in area of invasion
(detail of Fig. 10). x 92.
FIG. 12.-Granulosa-like cells (darkstaining) arising diffusely in islands of luteoma tissue
(detail ofFig. 10). x 92.
FIG. 13.-A microscopic granulosa cell tumour has grown to a bulk of tumour tissue. A
triangle shaped area of luteinized tissue is still recognizable in the centre of the tumour.
x 37.
FIG. 14.-Transitional stage between microscopic and macroscopic granulosa cell tumour.
Cysts are present and the formation of follicle-like structures is found. x 23.
FIG. 15.-Small focus of granulosa-like cells centrally in a luteinized preneoplastic ovary
(intraperitoneal DMBA). A " Sertoli body " is seen at the periphery (arrow). x 92.
FIG. 16. Macroscopic granulosa cell tumour showing highly differentiated growth with
formation of follicle-like structures. x 92.
FIG. 17.-Stroma cell tumour composed of stroma-like cells arranged in a pseudofollicular
pattern. x 92.
FIG. 18.-Autoradiogram ofpreneoplastic ovary prepared ofa section 5 js from Fig. 3. A focus
of luteinized tissue contains many labelled cells while adjacent areas of luteinized tissue
have not incorporated the label. x 230.
FIG. 19. Autoradiogram of a luteoma showing labelled cells in zone of invasion. x 370.
FIG. 20.-Autoradiogram of a macroscopic granulosa cell tumour with a follicular pattern
showing many labelled cells. x 370.
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When this progressed further a more specific pattern of tumour growth including
the formation of follicle-like structures could be found (Fig. 14).
The Mic. G. developing after intraperitoneal injection of DMBA appeared
somewhat differently. The tumour cells arose in the luteinized preneoplastic
ovaries in small foci (Fig. 15) or diffusely in larger areas.
(c) Macroscopic granulosa cell tumour (Mac. G.). These tumours were macro-
scopically recognizable and were composed predominantly of granulosa-like cells.
The histological pattern varied with the size; the smaller tumours were solid
without any particular arrangement of their cells while the large tumours were
highly differentiated showing follicle-like structures (Fig. 16) and Call-Exner
bodies. Haemorrhages, necrotic areas, and fibrous scars sometimes with
cartilage formation and ossification were seen. Parts of the tumours could
consist of pigmented tissue or stroma-like cells. No mitotic figures were seen in
these parts of the tumour while they were numerous in the granulosa-like tissue.
Oocytes, normal follicles or luteinized tissue were not observed.
A few tumours were composed exclusively of stroma-like cells arranged in
pseudofollicles similar to those seen in preneoplastic ovaries (Fig. 17). Such
" stroma cell tumours " were thought to represent a growth type different from
the Mac. G.
Proliferation pattern ofpathological ovarian tissue
Ten mice, fed with DMBA in immaturity, were injected intraperitoneally with
100 4uCi 3HTdR when aged 6 to 9 months and killed 1 hour later. Autoradio-
graphs were prepared of their ovaries (Table I, d). These 20 ovaries represented
various stages of the neoplastic ovarian development, which made it possible to
study the incorporation pattern ofthe labelled DNA-precursor into different types
of pathological ovarian tissue.
The few follicles present in potential preneoplastic ovaries showed a labelling
index of the granulosa cells comparable to that of normal mice (Pedersen and
Krarup, 1969). Some empty rings and pseudofollicles had a few labelled cells, but
the majority of them were unlabelled. In the diffusely luteinized central tissue
none or very few cells had incorporated the label. Pigmented tissue was unlabelled.
In some of the preneoplastic ovaries, however, luteinized areas or whole
"corpora" of luteinized cells (Fig. 3) had a high percentage of labelled cells
suggesting an active cell proliferation (Fig. 18). This was thought to be the first
stage of neoplastic proliferation recognized in the DMBA treated ovaries.
In the luteomnas a few cells became labelled and the labelling index was rather
low. However, in zones of invasion into the periovarian fat many cells incor-
porated the label (Fig. 19).
Foci ofMic. G. within a preneoplastic ovary or a luteoma had a high percentage
of labelled cells, while the remaining parts of the organ were labelled as described
above.
Many cells of the Mac. G. incorporated 3HTdR. Within the same tumour,
however, areas of low or no labelling as well as areas of high labelling were found.
Especially areas with a follicular pattern had many labelled cells (Fig. 20). Some
parts of the tumours thus seemed to proliferate faster than others. Areas within
the tumours composed of stroma-like cells or pigmented tissue never contained
labelled cells.
Labelled cells were only very rarely found in atrophic ovaries.
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Incidence of ovarian tumnours
The total incidence of animals with ovarian tumours, as well as the relative
incidence of the tumour types found in the different experimental groups at
various ages, are recorded in Fig. 21 and 22. Because of the small number of
mice killed at old age after intraperitoneal injection of DMBA in maturity-
a result of a high early mortality (Table I, g) -the tumour incidences in this group
are inconclusive. However, some trends may be deduced from the results of the
other groups. All mice finally developed tumours, but there was a difference in
the incidence of the different tumour types as well as in the speed, with which
tumours developed.
Luteoma was mainly seen in animals treated orally in immaturity. At 6
months the total tumour incidences after oral and intraperitoneal DMBAtreatment
in immaturity were 13/27 (48 %) and 19/28 (68 %) respectively. This was due to
an early development of Mic. G. in the intraperitoneally treated animals, while
most ovaries in the oral group at this age were still preneoplastic. At 9 months
many of the preneoplastic ovaries had developed further to luteoma or Mic. G.
and the total tumour incidence became comparable to that in the intraperitoneally
treated mice ofthe same age. However, in these animals the relative incidence of
Mac. G. was now considerably higher than among orally treated mice. It would
thus appear that tumour development occurred faster after intraperitoneal
injection than after oral ingestion.
Comparing mice treated orally at 21 days and at 4 months ofage, it is seen that
at 9 months the tumour incidences were comparable. In other words, the latency
period was considerably shorter when DMBA was administered to mature animals.
Vaginal smears
Vaginal smears were taken for 3 weeks on 55 control mice and 151 DMBA
treated animals at different ages before killing.
The smears were classified according to the degree of oestrogen stimulation:
(1) Anoestrus (AOE), i.e. no oestrogen stimulation. These snlears consisted
only of leucocytes, degenerated cells and mucus.
(2) Regular oestrus cycles (ROE) of 4 to 5 days' duration suggesting a regular,
cyclic oestrogen stimulation.
(3) Irregular oestrus cycles (IOE) suggesting an irregular oestrogen stimulation.
Mixed smears ofhigh cornification (cornified cells mixed with leucocytes, nucleated
cells and mucus cells) for 1 to 4 days' duration alternated with mixed smears of
low or no cornification for durations of up to 10 days.
(4) Permanent oestrus (POE) suggesting a continuous oestrogen stimulation
of the vagina. The smears showed cornified cells only or cornified cells predomi-
nantly mixed with leucocytes, nucleated cells or mucus cells.
Almost all ofthe control mice showedROE-smears. Thevaginal smear pattern
ofthe DMBA treated mice has been correlated with the pathology oftheir ovaries
(Table II); (as in Fig. 21 and 22 the mice have been classified according to the more
advanced of the two ovaries).
It appears that mice with early post treatment changes or potential pre-
neoplastic changes or luteoma usually showed ROE- or IOE-smears suggesting a
cyclic though often irregular oestrogen stimulation.
Half of the mice bearing a Mic. G. had ROE-, IOE-, or AOE-smears, while in
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TABLE II.-Vaginal Smears in Control and DMBA Treated Mice in Relation to
the Bilateral Ovarian Histology. Mice Showing Different Stages of Neoplastic
Development in the Two Ovaries are Classified by the More, Advanced Ovary
(Capitals).
Number ofmice with:
I A~~~~~Cntnosoetoe
Type ofovarian histology
CONTROL OVARIES (total 55 mice)
EARLY POST TREATMENT CHANGES
(total 16 mice)
POTENTIAL PRENEOPLASIA (total 19
mice)
potential preneoplasia (19 mice)
LUTEOMA (total 7 mice)
luteoma (3 mice)
potential preneoplasia (3 mice)
atrophy (1 mouse)
MIC. G. CELL TUMOUR (total 50 mice)
Mic. G. cell tumour (13 mice)
luteoma (11 mice)
potential preneoplasia (13 mice)
senile (1 mouse)
atrophy (12 mice)
MAC. G. CELL TUMOUR (total 56 mice)
stroma cell tumour (2 mice)
Mac. G. cell tumour (4 mice)
luteoma (1 mouse)
potential preneoplasia (1 mouse)
atrophy (48 mice)
No Cyclic oestrogen
oestrogen stimulation
stimulation,
AOE ROE IOE
2 . 53
Continuous oestrogen
stimulation
IOE-+POE POE
13
1 . 9 8
2
1
2
4
1
2
4
1
1
2
1
1
3
1
3
3
6
1
1
1
2
1
1
1
5
4
2
9
2
- 3
1
42
the other half IOE-smears followed by POE- or pure POE-smears were seen.
This was particularly marked when the ovary opposite to a Mic. G. was atrophic.
In the experimental mice so far mentioned regular, irregular or continuous
oestrogen stimulation occurred independent of whether a few oocytes were left
in the ovaries or total depletion ofoocytes had already been accomplished (Parkes,
1926; Zylicz et al., 1967).
Forty-eight mice out of56 with unilateral Mac. G. showedPOE-smears suggest-
ing a permanent oestrogen production by these tumours.
One mouse with bilateral " stroma cell tumour " and 2 mice with bilaterally
atrophied ovaries (not tabulated) had AOE-smears, i.e. no oestrogen stimulation.
Lesions Other Than Ovarian Tumours and Survival of Animals
Lesions other than ovarian tumours among control and experimental mice are
listed on Table III.
Pulmonary tumours were often seen and usually multiple. Their morphology
concurred with that described by Murphy (1966). They occurred spontaneously
among ageing control mice; DMBA, however, markedly enhanced their
development.
Leukaemia-except for a single case among the control mice (not listed)-
only occurred among DMBA treated mice. The disease was often generalized
including liver, spleen, thymus and lymph nodes, but isolated cases of thymic
enlargement occurred. This could be marked and cause the death of the mouse.
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Excrescences on the uterine horns were almost exclusively observed after
intraperitoneal injection of DMBA. They appeared as multiple small vesicles on
the uterine surface. Microscopically they were thin-walled cysts containing
lymphocytes or cell free fluid. As the deeper layers of the uterine wall showed
marked dilatation of lymph capillaries they probably represented cystic pro-
trusions belonging to the lymph system.
Ascites usually milky and peritoneal fibrinous adhesions were only seen in
intraperitoneally treated animals.
The incidence of mammary tumour was very low.
Death occurred in all groups of treated animals throughout the experiment.
(The figures are listed in Table I.) The frequent early death after intraperitoneal
injection has been noted previously (Kuwahara, 1967); it was due to peritonitis
or a general toxic action of the carcinogen. At times death was due to haemo-
peritoneum from ruptured ovarian tumours, or to pulmonary tumours, thymic
enlargement, or ileus.
Macroscopic ovarian tumours were frequently seen in mice that died spon-
taneously. Seven out of 10 mice and 11 out of 20 mice that had received oral and
intraperitoneal treatment in immaturity respectively and that died after the age
of 6 months, had unilateral macroscopic tumours. Among animals treated in
immaturity by oral and intraperitoneal route, 9 out of 12 mice and 4 out of 12 mice
respectively which died after the age of 8 months had a macroscopic ovarian
tumour.
DISCUSSION
Disappearance of oocytes and its relation to tumorigenesis
The reduction of the number of oocytes 1 month after DMBA treatment
(Marchant, 1957; Marchant, 1959b; Mody, 1960; Kuwahara, 1967) is due to a
direct and immediate destroying effect of DMBA on the small oocytes. After
oral administration of DMBA the number of developing oocytes in follicles is
secondarily reduced, while after intraperitoneal injection some follicles are directly
destroyed in addition (Krarup, 1969b). The immediate effect of DMBA on the
granulosa cells ofthe follicles, however, is a transient one, which causes a temporary
acceleration of the follicle growth rate; when this stimulating effect has subsided
the remaining follicles continue to develop normally (Pedersen and Krarup, 1969).
The labelling index of the last remaining follicles was normal and their ability to
ovulate was preserved (Fig. 4). Despite the severely reduced germ cell population
and advanced preneoplastic changes, the remaining oocytes which ovulate can be
fertilized and produce young (Krarup, not yet published).
Concurrently with the process of germ cell elimination pathological changes
develop in the ovaries. It has been suggested that the neoplastic development is
secondary to the premature elimination of oocytes and not caused by the carcino-
gen itself (Krarup, 1969a). This is supported by the observations that ovarian
tumours invariably develop following genetic deletion of germ cells (Russell and
Fekete, 1958; Murphy and Russell, 1963) and that, among four strains of mice,
spontaneous ovarian tumours only occurred in that particular strain whose ovaries
were physiologically exhausted of oocytes within the lifespan of the animals
(Jones and Krohn, 1961). That the loss ofoocytes and follicles after X-irradiation
" was correlated with the onset of active growth " was noted by Guthrie (1958),
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FIG. 21.-The bilateral ovarian histology and incidence of tumours at different ages after oral
and intraperitoneal DMBA administration at 4 months. The mice are classified by the more
advanced of the two ovaries according to a rising sequence of preference: potential preneo-
plasia-luteoma-microscopic granulosa cell tumour-macroscopic granulosa cell tumour-
starting from the left on the figures. This dominant ovary is given in the left half of the
double columns, while the less advanced of the two ovaries is indicated in the right half of
the double columns. (1) Bilateral leukemic infiltration, (2) stroma cell tumour.
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who found " the growth of the interstitial mass restrained in the presence of a
residual follicle ".
The present data confirm that the neoplastic ovarian development is correlated
with the elimination of germ cells. In 3-month-old animals the total number of
oocytes after feeding of DMBA on day 21 varied between 289 and 5 (Krarup,
1969b); the preneoplastic changes were less advanced in the presence of many
oocytes than when only few oocytes had survived, and Mic. G. had developed only
in those two mice whose ovaries were nearly depleted of oocytes. Furthermore,
the fact that the tumour development occurred faster after intraperitoneal
injection of DMBA than after oral ingestion (Fig. 22) can be correlated with a
faster destruction of oocytes in the intraperitoneally treated animals. Also the
shorter tumour latency period in mice treated orally at 4 months than on day 21
(Fig. 21 and 22) may be explained by the fact that depletion of oocytes occurred
faster in the 4-month-old animals (Krarup, 1969b). The delaying effect of
surviving oocytes with intact follicles on tumorigenesis is probably a phenomenon
similar to inhibition of tumour formation in the presence of a normal ovary after
DMBA induction (Marchant, 1960), X-irradiation (Lick et al., 1949; Kaplan, 1951)
and intrasplenic ovary transplantation (Biskind and Biskind, 1948; Li and
Gardner, 1949). It is most likely due to the production of steroids by surviving
follicles.
Histogenesis of ovarian tumours
Besides degeneration of oocytes, the early post-treatment changes include the
appearance of empty rings and pseudofollicles. These characteristic structures
have been noted by several authors after X-irradiation and described as " anovular
follicles ". Their origin is unclear and had been ascribed to (a) remnants of small
follicles in which the oocytes have degenerated, (b) differentiation of embryonal
cells lying dormant in the ovarian stroma or (c) formation from the germinal
(surface) epithelium (reviewed by Thung et al., 1956). In the present study
empty rings and pseudofollicles have not been observed to be connected with the
surface epithelium. That they are formed from follicles whose oocytes have
degenerated is unlikely, because oocytes in follicles which have a size comparable
to pseudofollicles (i.e. type 3b and type 4 follicles; Pedersen and Peters, 1968)
are not destroyed by DMBA. Their number decreases because the pool of small
oocytes-from which they are recruited-is reduced (Krarup, 1969b; Krarup et al.,
1969). Furthermore, there is a considerable discrepancy between the number of
empty rings and pseudofollicles present in a preneoplastic ovary and the number
of type 3b and type 4 follicles in a normal ovary. In one preneoplastic ovary
(Fig. 2) the total number ofempty rings and pseudofollicles was roughly estimated
to 1500 (counted on every tenth section), while the number oftype 3b and type 4
follicles in a normal ovary is limited to less than 300 (Krarup, 1969b). It is
therefore most likely, that empty rings and pseudofollicles have been formed from
cells belonging to ovarian stroma. In the immature mouse ovary, follicle cells
are known to derive from stroma cells (Peters and Pedersen, 1967) and it is
possible that such cells may differentiate to follicle-like structures under these
experimental conditions where oocytes are absent.
The potential preneoplastic changes, mainly characterized by diffuse luteiniza-
tion, have been described previously (Marchant, 1957; 1959b). This stage
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Fio;. 22.-The bilateral ovarian histology and incidence of tumours at different ages after oral
and intraperitoneal DMBA administration on day 21. For further explanation see Fig. 21.
(1) Total degeneration, (2) bilateral leukemic infiltration, (3) haemorrhagic cyst, (4) stroma
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represents the end point of the initiation phase; its further development into
tumour occurs only in the presence of the pituitary (promoting factor) (Marchant,
1961a).
The cellular components from which the tumour originates has been a matter
of discussion. According to Marchant the preneoplastic lutein tissue again
disappears and early tumours are considered to arise from remnants of follicles
(Marchant, 1957; Kuwahara, 1967), but such an origin cannot be the explanation
for late tumours (Marchant, 1959b). Luteinized tissue coexisting with granulosa
cell tumour was interpreted as a matter of maturation (Marchant, 1959a), and the
possibility of granulosa cell tumour arising in a pre-existing luteoma was denied
(Marchant, 1959b). Biancifiori et al. (1961), on the other hand, found it possible
that luteoma and granulosa cell tumour represented two phases of growth of the
same tumour, and Mody (1960) described foci of granulosa cells arising in aggre-
gates of thecal luteinization.
The results of the present study seem to express the following developmental
sequence. The stage of potential preneoplasia has a central position in the
process. It is well defined by its diffusely luteinized tissue, derived from confluent
corpora lutea and luteinized stroma, and its peripheral collection ofpseudofollicles
(Fig. 2). It develops during the process of oocyte elimination simultaneously in
the two ovaries resulting in a bilateral stage of preneoplasia (Fig. 22). It occurs
with a high incidence in the early phase ofdevelopment and becomes progressively
rarer as tumours develop.
That tumours develop from cells present in preneoplastic ovaries is suggested
autoradiographically by the fact that in luteinized tissue foci of cells had incor-
porated 3HTdR, i.e. proliferated (Fig. 18). It is likely that the luteinized cells by
proliferation give rise to undifferentiated (granulosa-like) daughter cells, which
continue their proliferation and form the granulosa cell tumour. The same type
of proliferation has been described for the intrasplenic rat ovary by Myhre (1962).
In the intraperitoneally treated mice no follicles were present in preneoplastic
ovaries. In these ovaries luteinized cells therefore seem to be the only possible
source of the Mic. G. (Fig. 15). However, after DMBA by mouth early Mic. G.
developed in preneoplastic ovaries that sometimes contained a residual follicle
(Fig. 9), and the possibility of abnormal growth from surviving follicles therefore
cannot be ruled out. Empty rings and pseudofollicles disappear slowly as tumours
develop, but persist as a broad rim in atrophic ovaries (Fig. 5). It is therefore
unlikely that they give rise to granulosa cell tumour. But the rare " stroma cell
tumour " (Fig. 17) which consists almost entirely of pseudofollicles may represent
the result of further growth of these structures. Luteomata are composed of the
same cellular components as preneoplastic ovaries but their lutein cells show
proliferation and invasion. They can be considered the result of neoplastic
transformation ofthe luteinized tissue ofpreneoplastic ovaries. Luteomata never
become macroscopic and lutein cells were not found in the large tumours in the
present study. Luteinization therefore cannot be considered as a matter of
maturation. Late Mic. G. developed within pre-existing luteomata depleted of
oocytes and follicles with granulosa-like cells found diffusely among the lutein cells
(Fig. 10, 11, 12). The lutein cells showed incorporation of 3HTdR as well as
mitotic activity. This would indicate that the late Mic. G. develop as the result
of proliferation of luteoma cells (Myhre, 1962).
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The bilateral evolution giving rise to unilateral tumour
Comparing the bilateral development, it is seen (Fig. 21 and 22) that pre-
neoplasia occurred in both ovaries and that luteoma and Mic. G. occurred uni-
laterally as well as bilaterally. Ifunilateral, the ovary opposite to a luteoma was
usually preneoplastic or atrophic, while the ovary contralateral to a Mic. G.
could be luteoma, preneoplastic or atrophic. Mac. G. was practically always
unilateral and opposite to an atrophic ovary. A possible sequence ofthis bilateral
ovarian development is suggested schematically in Fig. 23, which demonstrates
the multipotentiality of ovarian parenchyma to differentiate in several directions
dependent on the character ofthe hormonal environment.
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FIG. 23.-Scheme ofthe bilateral ovarian development leading to unilateral macroscopic granu-
losa cell tumour and contralateral atrophy. The sequence of bilateral stages of pathology
is correlated to the hormonal status as indicated by the type of vaginal smears.
Bilaterally existing preneoplastic ovaries have three possibilities for further
development: (1) Both of them progress to form a tumour (luteoma or Mic. G.);
or one ofthem develops into a tumour while the other one (2) remains preneoplastic
or (3) atrophies. When the Mic. G. develops further to form the Mac. G. the
opposite ovary invariably becomes atrophic.
The reason for this ultimate unilateral development may be found in changes
in the hormonal balance (Shisa and Nishizuka, 1968). The role ofoverstimulation
by pituitary gonadotrophins for the development of the tumours has been
described after X-irradiation (Miihlbock, 1953) and intrasplenic ovary trans-
plantation (Biskind and Biskind, 1944; Biskind et al., 1953; Lipschutz et al., 1964).
184DMBA OVARIAN TUMORIGENESIS IN MICE 185
Inboth situations, the ovaryloses its ability to control the output ofgonadotrophic
hormones soon after the induction procedure. Hypophysectomy prevents
tumorigenesis in the spleen-grafted ovary (Kullander, 1956) and also in the DMBA
treated ovary (Marchant, 1961a). Administration of oestrogen prevents tumori-
genesis in the intrasplenic ovary (Li and Gardner, 1949), as well as in the irradiated
ovary (Gardner, 1950), due to its suppressing action on gonadotrophic hormones.
A hormonal imbalance was found in most mice of the present study. Though
cyclic, the oestrogen stimulation of the vagina in mice with preneoplastic ovaries,
and often in mice with luteoma or Mic. G., was irregular with prolongation of
dioestrus and mixed oestrus smears. Similar changes were described byMarchant
(1957) before tumour development. This would indicate that as follicles disappear
the ability of the ovaries to produce the oestrogen necessary to control the pro-
duction and/or release of hypophyseal gonadotrophins is decreased. However,
other animals with Mic. G. showed permanent oestrus, suggestive of a continuous
oestrogen production by the tumour. This was especially marked in those mice
with Mic. G., in whom the contralateral ovary was atrophic. Nearly all mice
with Mac. G. and opposite atrophic ovaries showed signs ofa continuous oestrogen
production. It is therefore likely (Fig. 23) that a Mic. G.-developed from a
preneoplastic ovary or a luteoma under pituitary overstimulation-at a certain
time becomes autonomic and starts producing oestrogen, which via the feed-back
mechanism suppresses the production and/or release of pituitary gonadotrophins.
Thereby the opposite ovary (preneoplastic, luteoma, or not autonomous Mic.
G.) loses its pituitary stimulation necessary for further development. It there-
fore atrophies, whilethehormoneproducinggranulosa celltumour, nowindependent
of the presence of the pituitary (Kullander, 1956), continues its growth.
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